ID
31324
Descripción
Study ID: 104574 Clinical Study ID: AR1104574 Study Title: A randomized blinded pilot trial of fondaparinux sodium (Arixtra®) versus unfractionated heparin in addition to standard therapy in a broad range of patients undergoing percutaneous coronary intervention (ASPIRE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: fondaparinux sodium Trade Name: Arixtra Study Indication: Thromboembolism
Palabras clave
Versiones (1)
- 13/8/18 13/8/18 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
13 de agosto de 2018
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Fondaparinux sodium (Arixtra) versus unfractionated heparin with patients undergoing PCI; Clinical Study ID: AR1104574
Adverse Event Report
- StudyEvent: ODM
Descripción
Adverse event
Alias
- UMLS CUI-1
- C0877248
Descripción
Adverse event
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0877248
Descripción
Adverse event; Date of onset
Tipo de datos
date
Alias
- UMLS CUI [1]
- C2985916
Descripción
Adverse event; start time
Tipo de datos
time
Alias
- UMLS CUI [1]
- C2697889
Descripción
Adverse event; maximum intensity
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0518690
Descripción
Adverse event; Relationship; study drug
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0439849
- UMLS CUI [1,3]
- C0013230
Descripción
Adverse event; Relationship; study drug; action taken
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0439849
- UMLS CUI [1,3]
- C0013230
- UMLS CUI [1,4]
- C2826626
Descripción
Adverse event; Relationship; study drug; corrective therapies
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0439849
- UMLS CUI [1,3]
- C0013230
- UMLS CUI [1,4]
- C0087111
- UMLS CUI [1,5]
- C0719519
Descripción
Adverse event; Outcome
Tipo de datos
text
Alias
- UMLS CUI [1]
- C1705586
Descripción
Adverse event; seriousness criteria
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C1710056
Descripción
Adverse event; seriousness; date
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C1710056
- UMLS CUI [1,2]
- C0808070
Descripción
Adverse event; seriousness; time
Tipo de datos
time
Alias
- UMLS CUI [1,1]
- C1710056
- UMLS CUI [1,2]
- C1301880
Descripción
Adverse event; seriousness criteria
Tipo de datos
text
Alias
- UMLS CUI [1]
- C1710056
Descripción
Adverse event; significan bleeding
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C1301880
- UMLS CUI [1,2]
- C0019080
Similar models
Adverse Event Report
- StudyEvent: ODM
C2825181 (UMLS CUI [1,2])
C1300638 (UMLS CUI [1,3])
C2348585 (UMLS CUI [1,2])
C0518690 (UMLS CUI [1,2])
C0439849 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,3])
C0439849 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,3])
C2826626 (UMLS CUI [1,4])
C0439849 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,4])
C0719519 (UMLS CUI [1,5])
C0808070 (UMLS CUI [1,2])
C1301880 (UMLS CUI [1,2])
C0019080 (UMLS CUI [1,2])